InvestorsHub Logo
Followers 5
Posts 367
Boards Moderated 0
Alias Born 07/08/2011

Re: drobx post# 16071

Thursday, 02/14/2019 12:09:52 PM

Thursday, February 14, 2019 12:09:52 PM

Post# of 18425
Good points, I believe after over 10 yrs of developing, running trial after trial, its like a dog chasing its tail. things just keep going around in a circle with more and more dilution.
When I first came across the HP I thought it had great potential but for everything it claims to treat there always seems to be more effective ways to treat them by the time any trials get done. For ex. HCV, I remember the trials in India and all the big hullabaloo but then came better pharmaceutical trwatments and nothing ever became of the approval.
This company just keeps chasing the popular trend of the day but then a pharma treatment is approved which is a much easier and more effective way of treatment.
I think the only possible chance tbey have is if they can find a use for it that supplements and makes more effective oncology treatments which can be brutal with less than a 20% cure rate. They have made some headway with CTE but there again by the time they find its niche, get it tbrough trials and approved there will be more effective and less cumbersome ways of detection.

GLTA still holding
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News